Palatable orodispersible formulation of vortioxetine

GEP20267905BActive Publication Date: 2026-06-25ALKALOID SKOPJE
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
GE · GE
Patent Type
Patents
Current Assignee / Owner
ALKALOID SKOPJE
Filing Date
2023-09-27
Publication Date
2026-06-25
Patent Text Reader

Abstract

Orodispersible formulation of vortioxetine hydrobromide comprises granular component, polymeric component; and extragranular matrix. Granular component comprises vortioxetine salt together with inert carrier. Granular component is encapsulated into polymeric component.
Need to check novelty before this filing date? Find Prior Art